Physician profile
Daniel R Lane
NPI 1669494191
$15,605.06
in general payments reported to CMS, 2019-2025
25 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,985 · 2020: $101 · 2021: $6,498 · 2022: $803 · 2023: $387 · 2024: $495 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,217.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,495.33 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $221.84 | 2019-2025 | Perclot |
| Novo Nordisk INC | $164.91 | 2019-2024 | Wegovy |
| Tela Bio, INC. | $92.12 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $83.03 | 2020-2025 | Phasix Mesh |
| Endo Pharmaceuticals INC. | $75.59 | 2019-2021 | |
| Medtronic, INC. | $55.29 | 2021-2024 | V-Loc 180 |
| Integra Lifesciences Corporation | $43.65 | 2021-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $37.17 | 2021-2022 | |
| Tei Biosciences INC | $34.76 | 2019 | |
| Kci USA, INC. | $29.92 | 2023 | Bair Paws, Prevena Restor Arthroform |
| Bioventus LLC | $25.92 | 2022 | |
| Dilon Technologies, INC. | $25.71 | 2025 | Hemoblast Bellows |
| Standard Bariatrics, INC. | $25.46 | 2022 | |
| Endogastric Solutions, INC | $24.12 | 2023 | Esophyx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $23.45 | 2023 | |
| Intra-Sana Laboratories | $21.17 | 2024 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Acell, INC. | $20.98 | 2020 | |
| Polynovo North America LLC | $17.91 | 2022 | |
| Csl Behring | $15.67 | 2019 | |
| Redhill Biopharma INC. | $15.34 | 2021 | |
| Kerecis Limited | $14.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Heron Therapeutics, INC. | $14.17 | 2022 | |
| Allergan, INC. | $13.99 | 2019 | |
| Melinta Therapeutics, LLC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.